Background Paper to the Recommendation for the Preferential Use of Live-Attenuated Influenza Vaccine in Children Aged 2–6 Years in Germany

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - Germany
doi 10.1007/s00103-013-1844-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC